Skip to main content

J&J, Ethicon Face a Growing Number of Ventral Patch Lawsuits

J&J, Ethicon Face a Growing Number of Ventral Patch Lawsuits

J&J, Ethicon Face a Growing Number of Ventral Patch Lawsuits

Introduction

Apart from thousands of Physiomesh lawsuits filed against Johnson & Johnson and its Ethicon subsidiary, there is a steady increase in the number of product liability lawsuits over their Ethicon Proceed hernia patch. Recently, a new case was filed in New Jersey Superior Court by a plaintiff who faced complications due to the Ethicon Proceed Ventral Patch used during a hernia repair surgery in July 2014, resulting in revision surgeries and putting him in a situation of facing additional risks and complications.
 
Allegations include failure to warn despite having the knowledge of the associated risks and adverse effects, defectively designed product, withholding crucial information from FDA, and raising the chances of the risk of harm for individuals undergoing hernia repair.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!